Novel Therapeutics (PHAR4813)


This unit of study aims to expose students to emerging therapeutic and diagnostic biotechnologies. The unit expands on second and third year pharmaceutical science units of study by exploring novel and developing biotechnologies, such as gene therapy, vaccines, DNA arrays, cell therapies, novel diagnostic methods, new drug targets and drugs/therapies as well as clinical development processes. Sources of information for new biotechnology developments will be explored and practical exercises in interpreting and translating this information to patients and other health professionals will be provided. This unit of study will foster necessary skills to prepare pharmacists for their evolving roles associated with the choice, application and monitoring of new biotherapies. The exercises are designed to support the development of generic collaborative skills necessary for project work, such as planning and project management, conflict resolution and written and oral communication skills.

Our courses that offer this unit of study

Further unit of study information


Up to 30hrs of lectures, 8 x 3hr workshops and up to 40hrs of self directed learning and group work


Workshops (20%), written assignment (30%), final exam (50%)


Foye W.O et. al. Principles of Medicinal Chemistry (5th Ed), Williams and Wilkins (2002) Shargel L & Yu ABC Applied Biopharmaceutics and Pharmacokinetics (1999) Burton, Evans

Faculty/department permission required?


Unit of study rules


PHAR4811 and PHAR4812 and PHAR4823 and PHAR4814


PHAR4821 and PHAR4822

Study this unit outside a degree

Non-award/non-degree study

If you wish to undertake one or more units of study (subjects) for your own interest but not towards a degree, you may enrol in single units as a non-award student.

Cross-institutional study

If you are from another Australian tertiary institution you may be permitted to underake cross-institutional study in one or more units of study at the University of Sydney.